[Supplementary]Abstract 6948: A novel bispecific antibody-drug conjugate targeting CEACAM5 and CDH17 exhibits potent anti-tumor activity and enhanced tumor-selectivity

Post time 2026-6-4 09:05:34

journal：Cancer Research

Authors：Jinxiu Hou; Tingting Gu; Lisha Dong; Jiyuan Tian; Xiaoqian Chen; Dandan Liu; Yongxin Shang; Rongmei Yan; Kezhen Ye; Liang Tian; Jian Peng; Zhenping Zhu

Published date：2026-4-3

DOI：10.1158/1538-7445.am2026-6948

PDF link：https://aacrjournals.org/cancerr ... cific-antibody-drug

Article link：https://doi.org/10.1158/1538-7445.am2026-6948

Article Source：American Association for Cancer Research (AACR)。

Remark：

Post time 2026-6-4 09:05:35

: This post has been completed
Completed attachments will be deleted within 24 hours.

[AACR] [Supplementary]Abstract 6948: A novel bispecific antibody-drug conjugate targeting CEACAM5 and CDH17 exhibits potent anti-tumor activity and enhanced tumor-selectivity

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[AACR] [Supplementary]Abstract 6948: A novel bispecific antibody-drug conjugate targeting CEACAM5 and CDH17 exhibits potent anti-tumor activity and enhanced tumor-selectivity Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[AACR] [Supplementary]Abstract 6948: A novel bispecific antibody-drug conjugate targeting CEACAM5 and CDH17 exhibits potent anti-tumor activity and enhanced tumor-selectivity